Back

Targeting cardiac amyloidosis.

27 May 2019 (16:30 - 16:52)
Organised by:
Congress Presentation Part of: Upcoming and novel drugs in heart failure Drugs, Drug Targets HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Stephane Heymans

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Targeting fibrosis: pirfenidone and beyond.
Professor R. De Boer (Rotterdam, NL)
Presentation thumbnail
Elamipretide, to block mitochondrial dysfunction?
Professor C. Maack (Wuerzburg, DE)
Slides
Presentation thumbnail
Gene therapy.
Professor Y. Pinto (Amsterdam, NL)

Access the full session

Session thumbnail
Upcoming and novel drugs in heart failure

The Event

Event poster

Heart Failure 2019

27 May 2019 16:30 CET
You may be interested in
thumbnail
Congress Session
Cardiac amyloidosis: when translational approaches and personalised medicine become reality
13 May 2024
thumbnail
Congress Presentation
Prevalence and characterization of concealed cardiac amyloidosis among unselected elderly patients undergoing post-mortem examination
29 June 2021
thumbnail
Congress Presentation
Transthyretin-directed antisense oligonucleotide therapy effects on ATTRv myocardiopathy
20 May 2023
thumbnail
Webinar
The role of cardiac imaging for assessment of specific patient populations, according to new 2022 ESC Guidelines on Cardio-Oncology.
13 January 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources